Volitionrx (VNRX) Revenue (QoQ) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -100.70% |
| Sep 30, 2025 | 32.38% |
| Jun 30, 2025 | 65.06% |
| Mar 31, 2025 | 775.38% |
| Dec 31, 2024 | -108.98% |
| Sep 30, 2024 | 2.60% |
| Jun 30, 2024 | 130.74% |
| Mar 31, 2024 | -29.69% |
| Dec 31, 2023 | 47.67% |
| Sep 30, 2023 | -23.62% |
| Jun 30, 2023 | 44.39% |
| Mar 31, 2023 | 25.14% |
| Dec 31, 2022 | 265.94% |
| Sep 30, 2022 | -17.70% |
| Jun 30, 2022 | -65.19% |
| Mar 31, 2022 | 702.04% |
| Dec 31, 2021 | -44.12% |
| Sep 30, 2021 | 2.83% |
| Jun 30, 2021 | -2.93% |
| Mar 31, 2021 | 258.57% |
| Dec 31, 2020 | 1,138.26% |
| Sep 30, 2020 | -88.93% |
| Jun 30, 2020 | 1,608.55% |
| Mar 31, 2020 | -98.22% |
| Sep 30, 2012 | 135.66% |
| Jun 30, 2012 | -25.30% |